Media Advisory

CDC and FDA Joint Telebriefing on Investigation of Meningitis Outbreak

What

CDC and FDA will host a telephone-only media availability to discuss information about the multi-state investigation of meningitis among patients who have received epidural steroid injections.

When

Thursday, October 4 at 2 p.m. ET

Who

CDC, Benjamin Park, MD, medical officer, Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases,  National Center for Emerging and Zoonotic Infectious Diseases

FDA, Ilisa Bernstein, PharmD, JD, director, Office of Compliance, Center for Drug Evaluation and Research

Dial-In

* Please dial in 10 to 15 minutes before the start of the press conference.

DIAL-IN:
Media: 888-795-0855
Non-Media: 800-779-0740
INTERNATIONAL: 415-228-4996          
PASSCODE: Meningitis

Important Instructions
If you would like to ask a question during the call, press *1 on your touchtone phone. Press *2 to withdraw your question. You may queue up at any time. You will hear a tone to indicate your question is pending.

Transcript

A transcript of this press conference will be available following the briefing at www.cdc.gov/media.

###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES